These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1357 related items for PubMed ID: 10686072
1. Sequential administration of GDNF into the substantia nigra and striatum promotes dopamine neuron survival and axonal sprouting but not striatal reinnervation or functional recovery in the partial 6-OHDA lesion model. Rosenblad C, Kirik D, Björklund A. Exp Neurol; 2000 Feb; 161(2):503-16. PubMed ID: 10686072 [Abstract] [Full Text] [Related]
3. Glial cell line-derived neurotrophic factor prevents death, but not reductions in tyrosine hydroxylase, of injured nigrostriatal neurons in adult rats. Lu X, Hagg T. J Comp Neurol; 1997 Nov 24; 388(3):484-94. PubMed ID: 9368855 [Abstract] [Full Text] [Related]
4. Delivery of a GDNF gene into the substantia nigra after a progressive 6-OHDA lesion maintains functional nigrostriatal connections. Kozlowski DA, Connor B, Tillerson JL, Schallert T, Bohn MC. Exp Neurol; 2000 Nov 24; 166(1):1-15. PubMed ID: 11031079 [Abstract] [Full Text] [Related]
5. Behavioral and cellular protection of rat dopaminergic neurons by an adenoviral vector encoding glial cell line-derived neurotrophic factor. Choi-Lundberg DL, Lin Q, Schallert T, Crippens D, Davidson BL, Chang YN, Chiang YL, Qian J, Bardwaj L, Bohn MC. Exp Neurol; 1998 Dec 24; 154(2):261-75. PubMed ID: 9878166 [Abstract] [Full Text] [Related]
6. Protection and regeneration of nigral dopaminergic neurons by neurturin or GDNF in a partial lesion model of Parkinson's disease after administration into the striatum or the lateral ventricle. Rosenblad C, Kirik D, Devaux B, Moffat B, Phillips HS, Björklund A. Eur J Neurosci; 1999 May 24; 11(5):1554-66. PubMed ID: 10215908 [Abstract] [Full Text] [Related]
7. Characterization of behavioral and neurodegenerative changes following partial lesions of the nigrostriatal dopamine system induced by intrastriatal 6-hydroxydopamine in the rat. Kirik D, Rosenblad C, Björklund A. Exp Neurol; 1998 Aug 24; 152(2):259-77. PubMed ID: 9710526 [Abstract] [Full Text] [Related]
8. Effects of 6-hydroxydopamine on primary cultures of substantia nigra: specific damage to dopamine neurons and the impact of glial cell line-derived neurotrophic factor. Ding YM, Jaumotte JD, Signore AP, Zigmond MJ. J Neurochem; 2004 May 24; 89(3):776-87. PubMed ID: 15086533 [Abstract] [Full Text] [Related]
9. Bcl-2 and GDNF delivered by HSV-mediated gene transfer act additively to protect dopaminergic neurons from 6-OHDA-induced degeneration. Natsume A, Mata M, Goss J, Huang S, Wolfe D, Oligino T, Glorioso J, Fink DJ. Exp Neurol; 2001 Jun 24; 169(2):231-8. PubMed ID: 11358438 [Abstract] [Full Text] [Related]
10. Preservation of a functional nigrostriatal dopamine pathway by GDNF in the intrastriatal 6-OHDA lesion model depends on the site of administration of the trophic factor. Kirik D, Rosenblad C, Björklund A. Eur J Neurosci; 2000 Nov 24; 12(11):3871-82. PubMed ID: 11069582 [Abstract] [Full Text] [Related]
11. Delayed gene therapy of glial cell line-derived neurotrophic factor is efficacious in a rat model of Parkinson's disease. Zheng JS, Tang LL, Zheng SS, Zhan RY, Zhou YQ, Goudreau J, Kaufman D, Chen AF. Brain Res Mol Brain Res; 2005 Mar 24; 134(1):155-61. PubMed ID: 15790539 [Abstract] [Full Text] [Related]
12. Intrastriatal glial cell line-derived neurotrophic factor promotes sprouting of spared nigrostriatal dopaminergic afferents and induces recovery of function in a rat model of Parkinson's disease. Rosenblad C, Martinez-Serrano A, Björklund A. Neuroscience; 1998 Jan 24; 82(1):129-37. PubMed ID: 9483509 [Abstract] [Full Text] [Related]
13. 1,25-Dihydroxyvitamin D3 administration to 6-hydroxydopamine-lesioned rats increases glial cell line-derived neurotrophic factor and partially restores tyrosine hydroxylase expression in substantia nigra and striatum. Sanchez B, Relova JL, Gallego R, Ben-Batalla I, Perez-Fernandez R. J Neurosci Res; 2009 Feb 15; 87(3):723-32. PubMed ID: 18816795 [Abstract] [Full Text] [Related]
14. Protection of dopaminergic nigrostriatal afferents by GDNF delivered by microspheres in a rodent model of Parkinson's disease. Gouhier C, Chalon S, Aubert-Pouessel A, Venier-Julienne MC, Jollivet C, Benoit JP, Guilloteau D. Synapse; 2002 Jun 01; 44(3):124-31. PubMed ID: 11954043 [Abstract] [Full Text] [Related]
15. GDNF protects against 6-OHDA nigrostriatal lesion: in vivo study with microdialysis and PET. Opacka-Juffry J, Ashworth S, Hume SP, Martin D, Brooks DJ, Blunt SB. Neuroreport; 1995 Dec 29; 7(1):348-52. PubMed ID: 8742486 [Abstract] [Full Text] [Related]
16. Differential effects of glial cell line-derived neurotrophic factor (GDNF) in the striatum and substantia nigra of the aged Parkinsonian rat. Connor B, Kozlowski DA, Schallert T, Tillerson JL, Davidson BL, Bohn MC. Gene Ther; 1999 Dec 29; 6(12):1936-51. PubMed ID: 10637445 [Abstract] [Full Text] [Related]
18. Studies on neuroprotective and regenerative effects of GDNF in a partial lesion model of Parkinson's disease. Björklund A, Rosenblad C, Winkler C, Kirik D. Neurobiol Dis; 1997 Dec 29; 4(3-4):186-200. PubMed ID: 9361295 [Abstract] [Full Text] [Related]
19. Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine-lesioned rat model of Parkinson's disease. Chaturvedi RK, Shukla S, Seth K, Chauhan S, Sinha C, Shukla Y, Agrawal AK. Neurobiol Dis; 2006 May 29; 22(2):421-34. PubMed ID: 16480889 [Abstract] [Full Text] [Related]
20. Glial cell line-derived neurotrophic factor improves survival of dopaminergic neurons in transplants of fetal ventral mesencephalic tissue. Yurek DM. Exp Neurol; 1998 Oct 29; 153(2):195-202. PubMed ID: 9784279 [Abstract] [Full Text] [Related] Page: [Next] [New Search]